Specialty pharmaceuticals
Apollo’s Specialty Pharmaceuticals segment develops and markets innovative and competitive medicines to improve the lives and clinical outcomes of patients suffering from chronic, complex, or rare diseases around the world.
These medicines are frequently difficult to manufacture, prescribe, distribute, and administer, and may include novel formulations and combinations, as well as new applications that add value to known active ingredients. Specialty medicines play an important role in advancing healthcare by addressing unmet medical needs and reducing the financial burden on healthcare systems.
Broadening access to life-changing therapies through our specialist care
Some facts:
-
Medicine approved in EU.
-
Access to high quality biosimilars in European countries.
-
Long-standing biosimilar experience.
-
Our Specialty Pharmaceuticals portfolio includes a broad range of biosimilars and innovative products in challenging areas of therapy.
-
We are committed to enhancing the performance of our Specialty Pharmaceuticals business by continuously expanding our pipeline of medicines, developing our expertise and fostering trusted partnerships.
Which therapeutic areas does Apollo focus on?
Apollo focus on building partnerships that enable us to be a trusted partner in helping people get well. At present, we offer high quality medicines in the following therapeutic areas:
Anti-infectives
Anti-infective therapy is a broad area of medicine dedicated to the treatment…
Cardiovascular System
Cardiovascular therapy encompasses a wide range of treatments such as..
Central Nervous System (CNS)
The CNS therapy area encompasses a range of treatments and research…
